Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG; E, RdRP, N
Testing Method Category
Mixed
Testing Method
Multiple kits
Testing Method - Additional Info
Rapid IgM, IgG test: Acro Biotech, Inc.,Rancho Cucamonga, CA, USA). ; RT-PCR: Seegene Inc., Seoul, Korea
Reported Performance
Specificity: 94% (Rapid serological test); sensitivity 37% (Rapid serological test); PPV: 51% (Rapid serological test); NPV: 94% (Rapid serological test)
Sample Size
516 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements